SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-096390
Filing Date
2024-08-13
Accepted
2024-08-13 16:54:14
Documents
73
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cvsi-20240630.htm   iXBRL 10-Q 1726722
2 EX-2.5 cvsi-ex2_5.htm EX-2.5 365486
3 EX-31.1 cvsi-ex31_1.htm EX-31.1 14363
4 EX-31.2 cvsi-ex31_2.htm EX-31.2 13733
5 EX-32.1 cvsi-ex32_1.htm EX-32.1 6476
6 EX-32.2 cvsi-ex32_2.htm EX-32.2 6464
  Complete submission text file 0000950170-24-096390.txt   7761145

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT cvsi-20240630.xsd EX-101.SCH 1113175
76 EXTRACTED XBRL INSTANCE DOCUMENT cvsi-20240630_htm.xml XML 1166170
Mailing Address 9530 PADGETT STREET SUITE 107 SAN DIEGO CA 92126
Business Address 9530 PADGETT STREET SUITE 107 SAN DIEGO CA 92126 866-290-2157
CV Sciences, Inc. (Filer) CIK: 0001510964 (see all company filings)

IRS No.: 800944970 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54677 | Film No.: 241202561
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)